Patents Assigned to ND Partners LLC
  • Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
    Patent number: 9339036
    Abstract: The present invention relates to inhibiting or preventing infection and protecting against patency complications after a blood catheter has been inserted in a patient comprising administering to the device a pharmaceutically effective amount of a composition comprising (A) at least one taurinamide derivative, and (B) heparin at a low concentration.
    Type: Grant
    Filed: September 24, 2013
    Date of Patent: May 17, 2016
    Assignee: ND Partners, LLC
    Inventor: Frank R. Prosl
  • ANTIMICROBIAL LOCKING SOLUTIONS COMPRISING TAURINAMIDE DERIVATIVES AND BIOLOGICALLY ACCEPTABLE SALTS AND ACIDS, WITH THE ADDITION OF SMALL CONCENTRATIONS OF HEPARIN
    Publication number: 20140243323
    Abstract: The present invention relates to inhibiting or preventing infection and protecting against patency complications after a blood catheter has been inserted in a patient comprising administering to the device a pharmaceutically effective amount of a composition comprising: (A) at least one taurinamide derivative, (B) at least one compound selected from the group consisting of biologically acceptable acids and biologically acceptable salts thereof; and (C) heparin at a low concentration.
    Type: Application
    Filed: September 24, 2013
    Publication date: August 28, 2014
    Applicant: ND Partners, LLC
    Inventor: Frank R. Prosl
  • Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
    Patent number: 8541393
    Abstract: The present invention relates to inhibiting or preventing infection and protecting against patency complications after a blood catheter has been inserted in a patient comprising administering to the device a pharmaceutically effective amount of a composition comprising (A) at least one taurinamide derivative, (B) at least one compound selected from the group consisting of biologically acceptable acids and biologically acceptable salts thereof; and (C) heparin at a low concentration.
    Type: Grant
    Filed: September 2, 2011
    Date of Patent: September 24, 2013
    Assignee: ND Partners, LLC
    Inventor: Frank R. Prosl
  • Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
    Patent number: 7696182
    Abstract: The present invention relates to inhibiting or preventing infection and protecting against patency complications after a blood catheter has been inserted in a patient comprising administering to the device a pharmaceutically effective amount of a composition comprising: (A) at least one taurinamide derivative, (B) at least one compound selected from the group consisting of biologically acceptable acids and biologically acceptable salts thereof; and (C) heparin at a low concentration.
    Type: Grant
    Filed: November 2, 2004
    Date of Patent: April 13, 2010
    Assignee: ND Partners, LLC
    Inventor: Frank R. Prosl
  • Port device for subcutaneous access to the vascular system of a patient
    Patent number: 7131962
    Abstract: A port device for implanting in a patient for subcutaneous access to the vascular system of the patient. The device includes a housing provided with apertures, each for receiving and retaining a needle. The housing is further provided with lock structure for locking catheters to the housing. The housing is configured internally to provide flow paths extending between needles disposed in the apertures and the catheters.
    Type: Grant
    Filed: March 9, 2000
    Date of Patent: November 7, 2006
    Assignee: ND Partners LLC
    Inventors: Brian K. Estabrook, Paul J. Smith, Harold M. Martins, Frank R. Prosl
  • Peritoneal dialysis solution with taurolidine
    Patent number: 6803363
    Abstract: The present invention contemplates the addition of 0.5% to 4% taurolidine into solutions used peritoneal dialysis. The taurolidine is intended to prevent or reduce the incidence of infection within the abdomen and/or in the vicinity of an implanted dialysis port. The invention also includes methods using solutions of taurolidine in the flushing and locking of catheters and fluid lines used in peritoneal dialysis.
    Type: Grant
    Filed: May 31, 2002
    Date of Patent: October 12, 2004
    Assignee: ND Partners, LLC
    Inventor: Hans-Dietrich Polaschegg